InvestorsHub Logo
icon url

brick1981

12/18/12 8:37 AM

#11535 RE: RDBhan #11526

The selloff may be a bit premature. The conclusion of the docs state

"In summary, CFS is a serious, life threatening and unmet medical need. There are currently no FDA approved products specifically for the treatment of CFS. Ampligen has the potential to be a positive therapeutic option for patients with CFS who do not have an alternative to directly treat the condition. Given the overwhelming physical and cognitive health issues; the decrease in activities of daily living and overall lack of quality of life associated with CFS, Ampligen clearly represents a clinically meaningful advance for a significant unmet medical need, and the weight of evidence supports FDA goals to advance treatment for chronically ill patients with severe debilitating, life threatening, conditions such as severe CFS.
It can be stated that the burden of the symptoms associated with CFS is greater than any risks associated with Ampligen, since a CFS sufferer’s life may be at risk for years of debilitation often followed by premature death."

I think this has a chance to still get approved its panic selling for people not understanding how to read this thing.
icon url

rarefind

12/18/12 8:45 AM

#11538 RE: RDBhan #11526

Heb this sell off got me bullish as most of the time its the big players shaking out the little players and then watch for the re-bound. Heb has no chance to be approved is what people are saying.Then why did they over turn there ruling and deem the drug safe and agree to a hearing after 3 years of no? Heard the same stuff on arna,was that a ride.Call me a punter but i'll punt on this, 7000 in pre-market at @.43....rareF